Assessment of Antidepressant Effect of the Aerial Parts of Micromeria myrtifolia Boiss. & Hohen on Mice

Abstract

The currently available antidepressant agents necessitate the development of newer alternatives because of their serious adverse effects and costs. Traditional medicinal knowledge is likely the key that opens the door to discover new medicines. In Turkish folk medicine, the infusion prepared from aerial parts of Micromeria myrtifolia Boiss. & Hohen is used as pleasure and medicinal tea for its relaxing action. The present research was conceived to confirm the antidepressant’s potential of this traditional medicinal plant. In this process, first of all, the collected and shade-dried aerial parts of M. myrtifolia were powdered and then, extracted using solvents with different polarity as follows; n-hexane, ethyl acetate (EtOAc), and methanol (MeOH). The antidepressant activity of the extracts was evaluated by using several in vivo and in vitro experimental models of depression. When the data obtained from the control and experimental groups were compared, it was determined that the MeOH extract was the most active. The active components of this extract were isolated and identified utilizing various chromatographic separation techniques. The MeOH extract was applied to reversed phase (RP-18) column chromatography to obtain five main fractions and they were tested on antidepressant activity models. The isolated compounds from the obtained fractions were elucidated as rosmarinic acid (1), myricetin (2), apigenin (3), and naringenin (4) which were assumed to be responsible for the antidepressant activity of the aerial parts. According to the results, rosmarinic acid, myricetin, apigenin, and naringenin showed statistically significant activity on forced swimming test and tetrabenazine-induced ptosis models, whereas only rosmarinic acid showed statistically significant activity on the tail suspension test. Apigenin displayed the highest inhibitory activity on MAO A and B enzymes. Studies in the future should be performed to investigate the antidepressant activity mechanism of these natural compounds. The current research could be an important step in the development of the new agents that can be used in the treatment of depression.

Phytochemistry and pharmacological activity of the genus artemisia

“…Since these secondary metabolites are considered as the phenolic agents emerged from A. dracunculus and Stachys lavulifolia. Antidepressant properties of the extracts were examined in the forced swimming test (FST) along with the tail suspension test (TST) (Ahangar et al 2011;Akkol et al 2019). An open field test was performed to examine the usual locomotor actions in ice complying treatment with the extracts.…”

Unveiling Pharmacological Responses and Potential Targets Insights of Identified Bioactive Constituents of Cuscuta reflexa Roxb. Leaves through In Vivo and In Silico Approaches

“…Currently, selective serotonin and/or serotonin-norepinephrine reuptake inhibitors along with voltage-dependent calcium channels α2δ subunit ligands are considered as top-line synthetic antidepressant drugs of choice for treating chronic pain [40]. Likewise, standard pharmaceutical agents, some potential herbs such as California poppy, Saint John's Wort, Passionflower, Kava, and Saffron have been suggested for the management of anxiety, depression, and neurological based chronic pain [41].…”

In vitro and in vivo evaluation of pharmacological potential of Begonia barbata Wall

“…During the evaluation of CNS antidepressant property, the administration of B. barbata extract produced notable antidepressant activities. CNS antidepressant action of B. barbata may be due to the phytochemical composition of the extract [45,46].…”